Cone Dystrophy 3 C1865869
A genetic retinal disease damaging cone photoreceptors, leading to declining visual acuity and color vision. Treatment focuses on low vision support and adaptations.
Key facts at a glance
- ICD-10
- Q15.9
- ICD-11
- LA00.0
- Body system
- ophthalmologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Central vision loss
Generalized symptoms
(ophthalmologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Photophobia
(ophthalmologic)Color vision deficiency
(ophthalmologic)Nyctalopia
(ophthalmologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Regular ophthalmologic evaluation
Comprehensive eye exams including visual acuity testing, color vision assessment, and retinal imaging to track disease progression and adjust management.
UV and glare protection
Prescription sunglasses with blue-light blocking technology and wide-brimmed hats to reduce light sensitivity and protect remaining retinal function.
Additional treatment options
Nutritional supplementation
Antioxidant and vitamin supplementation (such as vitamin A, lutein, omega-3 fatty acids) to potentially support retinal health and slow progression.
complementaryVision rehabilitation counseling
Psychological support and counseling to address the emotional impact of progressive vision loss, including coping strategies and adjustment support.
psychologicalLow vision rehabilitation
Training in use of low vision aids such as magnifiers, specialized lighting, and adaptive technologies to maximize functional vision for daily activities.
physical_therapyWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Cone Dystrophy 3 C1865869?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Klein CA, Sander B, Smith SE. Consensus guidelines for the management of inherited retinal dystrophies. Ophthalmol Retina. 2022.
Michaelides M, Jeffery JA, Moore AT. Cone dystrophy: genetics and clinical features. Surv Ophthalmol. 2020.
Cideciyan AV, Jacobson SG, Ho AC. Novel therapeutic approach for ABCA4-related retinal disease. JAMA Ophthalmol. 2021.
Tucker BA, Mullins RF, Stone EM. Stem cell-based therapies for inherited retinal disorders: a systematic review and meta-analysis. Prog Retin Eye Res. 2023.
Medication Comparisons
Compare medications used to treat Cone Dystrophy 3 C1865869. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy